Established therapy update: Calcium channel blockers are effective and safe antihypertensive drugs

Cardiovascular Reviews and Reports

Volumn 22, Issue 3, 2001, Pages 189-191

  Chrysant, S G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ISRADIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; REVIEW;

EID: 0035103080     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Long-term antihypertensive effects with chronic administration of isradipine controlled release
2. Calcium Antagonists as antihypertensive agents are effective in all age groups
3. Calcium antagonists and renal protection: Current status and further perspectives
4. Long-term effects of isradipine on blood pressure and renal function
5. Renal and hemodynamic effects of isradipine in essential hypertension
6. Isradipine improves cardiac function in congestive heart failure
7. The risk of myocardial infarction associated with antihypertensive drug therapies
8. Calcium antagonists: Not appropriate as first line antihypertensive agents
9. Relevance of 24 h blood pressure profile and sympathetic activity for outcome on short- versus long-acting, 1,4-dihydropyridines
10. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension
11. Calcium channel blockers and cardiovascular prognosis in the European Trial on Isolated Systolic Hypertension
12. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
13. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension
14. Randomized trial of old and new hypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 Study
15. Morbidity and mortality in patients randomized to double-blind treatment with long-acting calcium channel blocker or diuretic in the international Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
16. Randomized trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study
17. Risk of serious adverse events in hypertensive patients receiving isradipine: A meta-analysis
18. Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTLE)
19. Clinical results of the verapamil in hypertension and atherosclerosis study
20. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives
21. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
22. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension (ABCD Trial)
23. Final outcome results of the Multi-Center Isradipine Diuretic Atherosclerosis Study (MIDAS)
24. Calcium channel blockers and mortality in elderly patients with myocardial infarction
25. First line drugs in chronic stable effort angina. The case for newer, long-acting calcium channel blocking agents